GSA Capital Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $96K | Sell |
|
|||||
|
2022
Q2 | $151K | Sell |
|
|||||
|
2022
Q1 | $309K | Sell |
|
|||||
|
2021
Q4 | $780K | Buy |
|
|||||
|
2021
Q3 | $143K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $134K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $177K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $486K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $185K | Sell |
|
|||||
|
2017
Q1 | $619K | Buy |
|
|||||
|
2016
Q4 | $214K | Buy |
|